Literature DB >> 33807612

Bacterial, Archaea, and Viral Transcripts (BAVT) Expression in Gynecological Cancers and Correlation with Regulatory Regions of the Genome.

Jesus Gonzalez-Bosquet1,2, Silvana Pedra-Nobre1, Eric J Devor2,3, Kristina W Thiel3, Michael J Goodheart1,2, David P Bender1,2, Kimberly K Leslie2,3.   

Abstract

Bacteria, archaea, and viruses are associated with numerous human cancers. To date, microbiome variations in transcription have not been evaluated relative to upper female genital tract cancer risk. Our aim was to assess differences in bacterial, archaea, and viral transcript (BAVT) expression between different gynecological cancers and normal fallopian tubes. In this case-control study we performed RNA sequencing on 12 normal tubes, 112 serous ovarian cancers (HGSC) and 62 endometrioid endometrial cancers (EEC). We used the centrifuge algorithm to classify resultant transcripts into four indexes: bacterial, archaea, viral, and human genomes. We then compared BAVT expression from normal samples, HGSC and EEC. T-test was used for univariate comparisons (correcting for multiple comparison) and lasso for multivariate modelling. For validation we performed DNA sequencing of normal tubes in comparison to HGSC and EEC BAVTs in the TCGA database. Pathway analyses were carried out to evaluate the function of significant BAVTs. Our results show that BAVT expression levels vary between different gynecological cancers. Finally, we mapped some of these BAVTs to the human genome. Numerous map locations were close to regulatory genes and long non-coding RNAs based on the pathway enrichment analysis. BAVTs may affect gynecological cancer risk and may be part of potential targets for cancer therapy.

Entities:  

Keywords:  archaea and viral transcripts; bacterial; endometrioid endometrial cancer; high grade serous ovarian cancer; metagenomics

Year:  2021        PMID: 33807612      PMCID: PMC7961894          DOI: 10.3390/cancers13051109

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  59 in total

Review 1.  The Microbiome of Oral Cancer.

Authors:  Edward J Shillitoe
Journal:  Crit Rev Oncog       Date:  2018

Review 2.  The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer.

Authors:  Seiji Mabuchi; Hiromasa Kuroda; Ryoko Takahashi; Tomoyuki Sasano
Journal:  Gynecol Oncol       Date:  2015-02-10       Impact factor: 5.482

3.  Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype.

Authors:  Daehwan Kim; Joseph M Paggi; Chanhee Park; Christopher Bennett; Steven L Salzberg
Journal:  Nat Biotechnol       Date:  2019-08-02       Impact factor: 54.908

4.  Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis).

Authors:  Jordane Biarc; Isabelle S Nguyen; Annelise Pini; Francine Gossé; Sophie Richert; Danielle Thiersé; Alain Van Dorsselaer; Emmanuelle Leize-Wagner; Francis Raul; Jean-Paul Klein; Marie Schöller-Guinard
Journal:  Carcinogenesis       Date:  2004-01-23       Impact factor: 4.944

Review 5.  The skin microbiome and immune system: Potential target for chemoprevention?

Authors:  Mohammad Asif Sherwani; Saba Tufail; Anum Fatima Muzaffar; Nabiha Yusuf
Journal:  Photodermatol Photoimmunol Photomed       Date:  2017-08-30       Impact factor: 3.135

6.  Strains, functions and dynamics in the expanded Human Microbiome Project.

Authors:  Jason Lloyd-Price; Anup Mahurkar; Gholamali Rahnavard; Jonathan Crabtree; Joshua Orvis; A Brantley Hall; Arthur Brady; Heather H Creasy; Carrie McCracken; Michelle G Giglio; Daniel McDonald; Eric A Franzosa; Rob Knight; Owen White; Curtis Huttenhower
Journal:  Nature       Date:  2017-09-20       Impact factor: 49.962

7.  Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy.

Authors:  Kosuke Murakami; Yasushi Kotani; Hidekatsu Nakai; Noriomi Matsumura
Journal:  Cancers (Basel)       Date:  2020-06-24       Impact factor: 6.639

8.  A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables.

Authors:  Erin A Salinas; Marina D Miller; Andreea M Newtson; Deepti Sharma; Megan E McDonald; Matthew E Keeney; Brian J Smith; David P Bender; Michael J Goodheart; Kristina W Thiel; Eric J Devor; Kimberly K Leslie; Jesus Gonzalez Bosquet
Journal:  Int J Mol Sci       Date:  2019-03-09       Impact factor: 5.923

9.  EGFR-Specific Tyrosine Kinase Inhibitor Modifies NK Cell-Mediated Antitumoral Activity against Ovarian Cancer Cells.

Authors:  Nina Mallmann-Gottschalk; Yvonne Sax; Rainer Kimmig; Stephan Lang; Sven Brandau
Journal:  Int J Mol Sci       Date:  2019-09-22       Impact factor: 5.923

10.  Differential DNA methylation in high-grade serous ovarian cancer (HGSOC) is associated with tumor behavior.

Authors:  Henry D Reyes; Eric J Devor; Akshaya Warrier; Andreea M Newtson; Jordan Mattson; Vincent Wagner; Gabrielle N Duncan; Kimberly K Leslie; Jesus Gonzalez-Bosquet
Journal:  Sci Rep       Date:  2019-11-29       Impact factor: 4.379

View more
  1 in total

Review 1.  The Role of Microbiota in the Immunopathogenesis of Endometrial Cancer.

Authors:  Małgorzata Sobstyl; Peet Brecht; Anna Sobstyl; Paulina Mertowska; Ewelina Grywalska
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.